|
UA59384C2
(uk)
*
|
1996-12-20 |
2003-09-15 |
Пфайзер, Інк. |
Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
|
|
ES2189142T3
(es)
*
|
1997-02-21 |
2003-07-01 |
Bayer Ag |
Arilsulfonamidas y sus analogos y su uso en el tratamiento de enfermedades neurodegenerativas.
|
|
AU759255B2
(en)
*
|
1998-01-29 |
2003-04-10 |
Amgen, Inc. |
PPAR-gamma modulators
|
|
DE19837627A1
(de)
|
1998-08-19 |
2000-02-24 |
Bayer Ag |
Neue Aminosäureester von Arylsulfonamiden und Analoga
|
|
US7041691B1
(en)
*
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
|
DE10015866A1
(de)
*
|
2000-03-30 |
2001-10-11 |
Bayer Ag |
Aryl- und Heteroarylsulfonate
|
|
US20090124690A1
(en)
*
|
2000-04-03 |
2009-05-14 |
Alberte Randall S |
Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins
|
|
AU6118001A
(en)
*
|
2000-05-03 |
2001-11-12 |
Tularik Inc |
Combination therapeutic compositions and methods of use
|
|
US20030171399A1
(en)
*
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
DE10047486A1
(de)
*
|
2000-09-26 |
2002-04-11 |
Bayer Ag |
Phenoxyphenyl Alkansulfonate
|
|
US20020091114A1
(en)
|
2000-10-04 |
2002-07-11 |
Odile Piot-Grosjean |
Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
|
|
UA75093C2
(en)
|
2000-10-06 |
2006-03-15 |
Dimensional Pharm Inc |
Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
|
|
AU2006200813A1
(en)
*
|
2000-11-24 |
2006-03-16 |
Novartis Ag |
Naphthalene derivatives
|
|
GB0028702D0
(en)
|
2000-11-24 |
2001-01-10 |
Novartis Ag |
Organic compounds
|
|
US6708906B2
(en)
*
|
2000-12-29 |
2004-03-23 |
Siemens Automotive Corporation |
Modular fuel injector having a surface treatment on an impact surface of an electromagnetic actuator and having an integral filter and dynamic adjustment assembly
|
|
US7507767B2
(en)
*
|
2001-02-08 |
2009-03-24 |
Schering Corporation |
Cannabinoid receptor ligands
|
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
|
US20040171613A1
(en)
*
|
2001-12-27 |
2004-09-02 |
Japan Tobacco Inc. |
Therapeutic agent for non-immediate type allergic diseases
|
|
WO2003061699A1
(en)
*
|
2001-12-27 |
2003-07-31 |
Japan Tobacco, Inc. |
Remedies for allergic diseases
|
|
AU2003211442A1
(en)
*
|
2002-02-19 |
2003-09-09 |
Shionogi And Co., Ltd. |
Antipruritics
|
|
JP2005533748A
(ja)
|
2002-03-08 |
2005-11-10 |
シグナル ファーマシューティカルズ，インコーポレイテッド |
増殖性障害および癌を治療、予防、または管理するための併用療法
|
|
WO2003077847A2
(en)
|
2002-03-12 |
2003-09-25 |
Merck & Co., Inc. |
Substituted amides
|
|
JP2005528366A
(ja)
|
2002-03-26 |
2005-09-22 |
メルク エンド カムパニー インコーポレーテッド |
カンナビノイド受容体モジュレータとしてのスピロ環式アミド
|
|
JP2005531520A
(ja)
|
2002-03-28 |
2005-10-20 |
メルク エンド カムパニー インコーポレーテッド |
置換２，３−ジフェニルピリジン類
|
|
DE10215942A1
(de)
*
|
2002-04-11 |
2003-10-23 |
Bayer Ag |
Wässrige Formulierungen von (2-Hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorbutan-1-sulfonat
|
|
WO2003086288A2
(en)
|
2002-04-12 |
2003-10-23 |
Merck & Co., Inc. |
Bicyclic amides
|
|
US6908935B2
(en)
|
2002-05-23 |
2005-06-21 |
Amgen Inc. |
Calcium receptor modulating agents
|
|
US7176322B2
(en)
|
2002-05-23 |
2007-02-13 |
Amgen Inc. |
Calcium receptor modulating agents
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
US7094789B2
(en)
|
2002-07-22 |
2006-08-22 |
Asahi Kasei Pharma Corporation |
5-substituted isoquinoline derivatives
|
|
JP2006504667A
(ja)
*
|
2002-08-08 |
2006-02-09 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
炎症過程に関与するサイトカインの抑制剤としてのフッ素化フェニル−ナフタレニル−尿素化合物
|
|
CA2499497A1
(en)
|
2002-09-27 |
2004-04-08 |
Merck & Co., Inc. |
Substituted pyrimidines
|
|
WO2004058709A1
(en)
*
|
2002-12-23 |
2004-07-15 |
Millennium Pharmaceuticals, Inc. |
Ccr8 inhibitors
|
|
TW200510311A
(en)
*
|
2002-12-23 |
2005-03-16 |
Millennium Pharm Inc |
CCr8 inhibitors
|
|
US7491827B2
(en)
*
|
2002-12-23 |
2009-02-17 |
Millennium Pharmaceuticals, Inc. |
Aryl sulfonamides useful as inhibitors of chemokine receptor activity
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
WO2005037286A1
(en)
|
2003-03-25 |
2005-04-28 |
Vasopharm Biotech Gmbh |
Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia
|
|
MXPA06002780A
(es)
|
2003-09-11 |
2006-06-14 |
Tibotec Pharm Ltd |
Inhibidores de entrada del virus de vih.
|
|
CA2538291A1
(en)
*
|
2003-09-18 |
2005-03-31 |
Merck & Co., Inc. |
Substituted sulfonamides
|
|
US7547693B2
(en)
|
2003-09-22 |
2009-06-16 |
Banyu Pharmaceutical Co. Ltd. |
Piperidine derivative
|
|
US7223761B2
(en)
*
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
|
TW200522944A
(en)
|
2003-12-23 |
2005-07-16 |
Lilly Co Eli |
CB1 modulator compounds
|
|
EP1722789A2
(en)
*
|
2004-03-08 |
2006-11-22 |
Amgen Inc. |
Therapeutic modulation of ppar (gamma) activity
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
AU2005286592A1
(en)
*
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyrimidine compounds, process for their preparation and compositions containing them
|
|
ATE427759T1
(de)
|
2004-11-01 |
2009-04-15 |
Amylin Pharmaceuticals Inc |
Behandlung von fettsucht und verbundenen erkrankungen
|
|
US8394765B2
(en)
*
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
|
EP1820504A1
(en)
*
|
2004-11-15 |
2007-08-22 |
Taisho Pharmaceutical Co., Ltd |
Imine compound
|
|
WO2006093253A1
(ja)
*
|
2005-03-03 |
2006-09-08 |
Santen Pharmaceutical Co., Ltd. |
キノリルアルキルチオ基を有する新規環式化合物
|
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
|
KR101397913B1
(ko)
|
2005-05-30 |
2014-05-26 |
엠에스디 가부시키가이샤 |
신규 피페리딘 유도체
|
|
CA2613678A1
(en)
|
2005-06-02 |
2006-12-07 |
Glenmark Pharmaceuticals S.A. |
Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
|
|
US7923465B2
(en)
|
2005-06-02 |
2011-04-12 |
Glenmark Pharmaceuticals S.A. |
Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
|
|
JPWO2007018248A1
(ja)
|
2005-08-10 |
2009-02-19 |
萬有製薬株式会社 |
ピリドン化合物
|
|
BRPI0614649A2
(pt)
|
2005-08-11 |
2011-04-12 |
Amylin Pharmaceuticals Inc |
polipeptìdeos hìbridos com propriedades selecionáveis
|
|
EP1922336B1
(en)
|
2005-08-11 |
2012-11-21 |
Amylin Pharmaceuticals, LLC |
Hybrid polypeptides with selectable properties
|
|
JPWO2007024004A1
(ja)
|
2005-08-24 |
2009-03-05 |
萬有製薬株式会社 |
フェニルピリドン誘導体
|
|
JPWO2007029847A1
(ja)
|
2005-09-07 |
2009-03-19 |
萬有製薬株式会社 |
二環性芳香族置換ピリドン誘導体
|
|
CA2624030A1
(en)
|
2005-09-29 |
2007-04-12 |
Tianying Jian |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
EP1944301A4
(en)
|
2005-10-27 |
2012-01-04 |
Msd Kk |
NEW BENZOXATHIIN DERIVATIVES
|
|
WO2007055418A1
(ja)
|
2005-11-10 |
2007-05-18 |
Banyu Pharmaceutical Co., Ltd. |
アザ置換スピロ誘導体
|
|
US7935715B2
(en)
*
|
2006-07-28 |
2011-05-03 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the CB2 receptor
|
|
CA2664113C
(en)
|
2006-09-22 |
2013-05-28 |
Merck & Co., Inc. |
Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
|
|
JP5030114B2
(ja)
*
|
2006-09-25 |
2012-09-19 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｂ２受容体をモジュレートする化合物
|
|
AU2007301126A1
(en)
|
2006-09-28 |
2008-04-03 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
|
WO2008098025A1
(en)
*
|
2007-02-08 |
2008-08-14 |
Boehringer Ingelheim International Gmbh |
Arylsulfonamide compounds which modulate the cb2 receptor
|
|
EP2145884B1
(en)
|
2007-04-02 |
2014-08-06 |
Msd K.K. |
Indoledione derivative
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
ES2559319T3
(es)
|
2007-06-04 |
2016-02-11 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato cliclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
JP5492092B2
(ja)
*
|
2007-11-07 |
2014-05-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｂ２受容体を調節する化合物
|
|
WO2009064298A1
(en)
*
|
2007-11-14 |
2009-05-22 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity and obesity related diseases and disorders
|
|
EP2264026A4
(en)
|
2008-03-06 |
2012-03-28 |
Msd Kk |
ALKYLAMINOPYRIDINDERIVATE
|
|
EP2272841A1
(en)
|
2008-03-28 |
2011-01-12 |
Banyu Pharmaceutical Co., Ltd. |
Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
|
|
EP2328910B1
(en)
|
2008-06-04 |
2014-08-06 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
WO2009154132A1
(ja)
|
2008-06-19 |
2009-12-23 |
萬有製薬株式会社 |
スピロジアミン-ジアリールケトオキシム誘導体
|
|
EP2326629B1
(en)
*
|
2008-07-10 |
2013-10-02 |
Boehringer Ingelheim International GmbH |
Sulfone compounds which modulate the cb2 receptor
|
|
US20110124674A1
(en)
|
2008-07-30 |
2011-05-26 |
Hiroyuki Kishino |
5/5-or 5/6-membered condensed ring cycloalkylamine derivative
|
|
BRPI0919172A2
(pt)
*
|
2008-09-25 |
2015-12-15 |
Boehringer Ingelheim Int |
compostos os quais modulam seletivamente o receptor de cb2
|
|
CA2741125A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
KR101320245B1
(ko)
|
2008-10-30 |
2013-10-30 |
머크 샤프 앤드 돔 코포레이션 |
이소니코틴아미드 오렉신 수용체 길항제
|
|
US8329914B2
(en)
|
2008-10-31 |
2012-12-11 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
WO2010075069A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Bicyclic pyranone derivatives as nicotinic acid receptor agonists
|
|
WO2010075068A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
EP2379076B1
(en)
|
2008-12-23 |
2014-11-12 |
The Trustees of Columbia University in the City of New York |
Phosphodiesterase inhibitors and uses thereof
|
|
US8299103B2
(en)
|
2009-06-15 |
2012-10-30 |
Boehringer Ingelheim International Gmbh |
Compounds which selectively modulate the CB2 receptor
|
|
WO2010147791A1
(en)
|
2009-06-16 |
2010-12-23 |
Boehringer Ingelheim International Gmbh |
Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
|
|
EP2480544A1
(en)
*
|
2009-09-22 |
2012-08-01 |
Boehringer Ingelheim International GmbH |
Compounds which selectively modulate the cb2 receptor
|
|
EA019970B8
(ru)
|
2009-12-11 |
2014-11-28 |
Отифони Терапеутикс Лимитед |
Производные имидазолидиндиона
|
|
WO2011088015A1
(en)
|
2010-01-15 |
2011-07-21 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
|
CA2786314A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
EP2542539B1
(en)
|
2010-03-05 |
2014-02-26 |
Boehringer Ingelheim International GmbH |
Tetrazole compounds which selectively modulate the cb2 receptor
|
|
WO2012012307A1
(en)
|
2010-07-22 |
2012-01-26 |
Boehringer Ingelheim International Gmbh |
Sulfonyl compounds which modulate the cb2 rece
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
EP3243385B1
(en)
|
2011-02-25 |
2021-01-13 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
|
RU2015106909A
(ru)
|
2012-08-02 |
2016-09-27 |
Мерк Шарп И Доум Корп. |
Антидиабетические трициклические соединения
|
|
KR20150118158A
(ko)
|
2013-02-22 |
2015-10-21 |
머크 샤프 앤드 돔 코포레이션 |
항당뇨병 비시클릭 화합물
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
WO2014151200A2
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
EP2803668A1
(en)
|
2013-05-17 |
2014-11-19 |
Boehringer Ingelheim International Gmbh |
Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
|
|
BR112015030326A2
(pt)
|
2013-06-05 |
2017-08-29 |
Synergy Pharmaceuticals Inc |
Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
DK3054936T5
(da)
|
2013-10-10 |
2024-03-18 |
Eastern Virginia Medical School |
4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
|
|
ES2901114T3
(es)
|
2014-08-29 |
2022-03-21 |
Tes Pharma S R L |
Inhibidores de ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa
|
|
US9585867B2
(en)
|
2015-08-06 |
2017-03-07 |
Charles Everett Ankner |
Cannabinod formulation for the sedation of a human or animal
|
|
MX2019004321A
(es)
|
2016-10-14 |
2019-06-12 |
Tes Pharma S R L |
Inhibidores de la acido alfa-amino-beta-carboximuconico semialdehido descarboxilasa.
|
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
IL283182B2
(en)
|
2018-11-20 |
2025-10-01 |
Tes Pharma S R L |
Alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase inhibitors
|
|
WO2020167706A1
(en)
|
2019-02-13 |
2020-08-20 |
Merck Sharp & Dohme Corp. |
5-alkyl pyrrolidine orexin receptor agonists
|
|
US12331018B2
(en)
|
2019-02-13 |
2025-06-17 |
Merck Sharp & Dohme Llc |
Pyrrolidine orexin receptor agonists
|
|
EP4010314B1
(en)
|
2019-08-08 |
2024-02-28 |
Merck Sharp & Dohme LLC |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
|
|
US20230365533A1
(en)
|
2020-08-18 |
2023-11-16 |
Merck Sharp & Dohme Llc |
Bicycloheptane pyrrolidine orexin receptor agonists
|